pI: 10.2315 |
Length (AA): 234 |
MW (Da): 25883 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 2
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 2 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
48 | 147 | 5azx (A) | 31 | 128 | 17.00 | 0.000025 | 0.11 | 0.55165 | 0.28 |
112 | 165 | 2qp2 (A) | 314 | 366 | 32.00 | 0.53 | 0.02 | 0.389969 | 1.46 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | VEG Tachyzoite, ME49 Tachyzoite, ME49 merozoite, ME49 Oocyst. | Gregory Hehl AB Fritz HM |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | ME49 Bradyzoite. | Sibley/Greg |
Gregory | ToxoDB |
Hehl AB | Asexual expansion of Toxoplasma gondii merozoites is distinct from tachyzoites and entails expression of non-overlapping gene families to attach, invade, and replicate within feline enterocytes. |
Fritz HM | Transcriptomic analysis of toxoplasma development reveals many novel functions and structures specific to sporozoites and oocysts. |
Sibley/Greg | ToxoDB |
Ortholog group members (OG5_127900)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT3G10780 | emp24/gp25L/p24 family/GOLD domain-containing protein |
Arabidopsis thaliana | AT1G57620 | emp24/gp25L/p24 family/GOLD domain-containing protein |
Arabidopsis thaliana | AT1G21900 | p24 subfamily delta 5 |
Arabidopsis thaliana | AT1G09580 | transmembrane emp24 domain-containing protein p24delta3 |
Babesia bovis | BBOV_III006340 | membrane protein, putative |
Brugia malayi | Bm1_55295 | Transmembrane protein |
Candida albicans | CaO19.7409 | Component of COPII coat of ER-derived vesicles |
Caenorhabditis elegans | CELE_F47G9.1 | Protein F47G9.1 |
Cryptosporidium parvum | cgd1_430 | possible emp24/gp25L/p24 family protein, transmembrane domain |
Dictyostelium discoideum | DDB_G0277923 | hypothetical protein |
Drosophila melanogaster | Dmel_CG11785 | baiser |
Echinococcus granulosus | EgrG_000544600 | transmembrane emp24 domain containing protein |
Entamoeba histolytica | EHI_058320 | transmembrane protein tmp21, putative |
Echinococcus multilocularis | EmuJ_000544600 | transmembrane emp24 domain containing protein |
Homo sapiens | ENSG00000170348 | transmembrane emp24-like trafficking protein 10 (yeast) |
Leishmania braziliensis | LbrM.34.1760 | COP-coated vesicle membrane protein gp25L precursor, putative,ER--golgi transport protein gp25L, putative |
Leishmania donovani | LdBPK_351840.1 | COP-coated vesicle membrane protein gp25L precursor, putative |
Leishmania infantum | LinJ.35.1840 | COP-coated vesicle membrane protein gp25L precursor, putative,ER--golgi transport protein gp25L, putative |
Leishmania major | LmjF.35.1850 | COP-coated vesicle membrane protein gp25L precursor, putative,ER--golgi transport protein gp25L, putative |
Leishmania mexicana | LmxM.34.1850 | COP-coated vesicle membrane protein gp25L precursor, putative,ER--golgi transport protein gp25L, putative |
Loa Loa (eye worm) | LOAG_00194 | transmembrane protein |
Mus musculus | ENSMUSG00000021248 | transmembrane emp24-like trafficking protein 10 (yeast) |
Neospora caninum | NCLIV_042050 | hypothetical protein |
Oryza sativa | 4330850 | Os02g0768200 |
Oryza sativa | 4332955 | Os03g0376000 |
Oryza sativa | 4340456 | Os06g0210100 |
Oryza sativa | 4344005 | Os07g0632700 |
Plasmodium berghei | PBANKA_1348000 | transmembrane protein Tmp21 homologue, putative |
Plasmodium falciparum | PF3D7_1333300 | transmembrane protein Tmp21 homologue, putative |
Plasmodium knowlesi | PKNH_1267300 | transmembrane protein Tmp21 homologue, putative |
Plasmodium vivax | PVX_082595 | hypothetical protein, conserved |
Plasmodium yoelii | PY06414 | transmembrane protein tmp21 precursor |
Saccharomyces cerevisiae | YML012W | Erv25p |
Schistosoma japonicum | Sjp_0025150 | Transmembrane emp24 domain-containing protein 10 precursor, putative |
Schistosoma mansoni | Smp_079310 | transmembrane protein tmp21-related |
Schmidtea mediterranea | mk4.010203.00 | Transmembrane protein tmp21-related |
Trypanosoma brucei gambiense | Tbg972.9.9350 | COP-coated vesicle membrane protein gp25L precursor, putative,ER--golgi transport protein gp25L, putative |
Trypanosoma brucei | Tb927.9.15090 | cytosolic coat protein, putative |
Trypanosoma congolense | TcIL3000_9_6310 | ER--golgi transport protein gp25L, putative |
Trypanosoma cruzi | TcCLB.510765.30 | COP-coated vesicle membrane protein gp25L precursor, putative |
Trypanosoma cruzi | TcCLB.509671.90 | ER--golgi transport protein gp25L, putative |
Toxoplasma gondii | TGME49_289800 | hypothetical protein |
Theileria parva | TP02_0330 | hypothetical protein |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb09.244.2760 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb09.244.2760 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb09.244.2760 | Trypanosoma brucei | significant loss of fitness in procyclic forms | alsford |
Tb09.244.2760 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_F47G9.1 | Caenorhabditis elegans | embryonic lethal | wormbase |
PBANKA_1348000 | Plasmodium berghei | Dispensable | plasmo |
TGME49_289800 this record | Toxoplasma gondii | Probably essential | sidik |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.